Akt: A Therapeutic Target in Hepatic Ischemia–Reperfusion Injury

References

• Unos.org. Transplant trends. Online Data Base|United Network of Organ Sharing, 2015.
   Google Scholar
• Mullonkal CJ, Toledo-Pereyra LH. Akt in ischemia and reperfusion. J Invest Surg. 2007;20(3):195–203.
   PubMed Web of Science ®Google Scholar
• Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med. +2005;9(1):59–71
   PubMed Web of Science ®Google Scholar
• Staal SP, Hartley JW, Rowe WP. Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc Natl Acad Sci USA 1977;74(7):3065–3067.
   PubMed Web of Science ®Google Scholar
• Bellacosa A, Testa JR, Staal SP, Tsichlis PN. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 1991;254(5029):274–277
   PubMed Web of Science ®Google Scholar
• Grammer TC, Cheatham L, Chou MM, Blenis J. The p70(S6K) signalling pathway: A novel signalling system involved in growth regulation. Cancer Surv. 1996;27:271–292.
   PubMedGoogle Scholar
• Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997;275(5300):661–665.
   PubMed Web of Science ®Google Scholar
• Datta SR, Dudek H, Xu T, Masters S, Haian F, Gotoh Y, et al. Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery. Cell 1997;91(2):231–241.
   PubMed Web of Science ®Google Scholar
• Ouyang Y, Tan Y, Comb M, Liu C, Marione ME, Siesjö BK, et al. Survival- and death-promoting events after transient cerebral ischemia: Phosphorylation of Akt, release of cytochrome C, and activation of caspase—like proteases. J Cereb Blood Flow Metab. 1999;19(10):1126–1135.
   PubMed Web of Science ®Google Scholar
• Kitagawa H, Warita H, Sasaki C, Ri Zhang W, Sakai K, Shiro Y, et al. Immunoreactive Akt, PI3-K and ERK protein kinase expression in ischemic rat brain. Neurosci Lett. 1999;274(1):45–48.
   PubMed Web of Science ®Google Scholar
• Li J, Li R, Lv G, Liu H. The mechanisms and strategies to protect from hepatic ischemia–reperfusion injury. Eur Rev Med Pharmacol Sci. 2015;19(11):2036–2047.
   PubMed Web of Science ®Google Scholar
• Chang WJ, Chehab M, Kink S, Toledo-Pereyra LH. Intracellular calcium signaling pathways during liver ischemia and reperfusion. J Invest Surg. 2010;23(4):228–238.
   PubMed Web of Science ®Google Scholar
• Weigand K, Brost S, Steinebrunner N, Bchler M, Schemmer P, Müller M. Ischemia/Reperfusion injury in liver surgery and transplantation: Pathophysiology. HPB Surg. 2012;2012.
   Google Scholar
• Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol. 2003;18(8):891–902.
   PubMed Web of Science ®Google Scholar
• Southard JH, Marshu DC, McAnulty JF, Belzer FO. Oxygen-derived free radical damage in organ preservation: Activity of superoxide dismutase and xanthine oxidase. Surgery (USA ) 1987;101(5):566–570.
   PubMed Web of Science ®Google Scholar
• Peglow S, Toledo AH, Anaya-Prado R, Lopez-Neblina F, Toledo-Pereyra LH. Allopurinol and xanthine oxidase inhibition in liver ischemia reperfusion. J Hepato-Biliary-Pancreatic Sci. 2011;18(2):137–146.
   PubMed Web of Science ®Google Scholar
• Amacher DE. Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul Toxicol Pharmacol. 1998;27(2):119–130.
   PubMed Web of Science ®Google Scholar
• Sherman KE. Alanine Aminotransferase in Clinical Practice: A Review. Arch Intern Med. 1991;151(2):260–265.
   PubMedGoogle Scholar
• Tang B, Qiao H, Meng F, Sun X. Glycyrrhizin attenuates endotoxin-induced acute liver injury after partial hepatectomy in rats. Braz J Med Biol Res. 2007;40(12):1637–1646.
   PubMed Web of Science ®Google Scholar
• Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;74(5):1124–1136.
   PubMed Web of Science ®Google Scholar
• Carini R, De Cesaris MG, Splendore R, Baldanzi G, Nitti MP, Alchera E, et al. Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning. Gastroenterology 2004;127(3):914–923.
   PubMed Web of Science ®Google Scholar
• Izuishi K, Tsung A, Hossain MA, Fujiwara M, Wakabayashi H, Masaki T, et al. Ischemic preconditioning of the murine liver protects through the Akt kinase pathway. Hepatology 2006;44(3):573–580.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Corvera JS, Halkos ME, Kerendi F, Wang N, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285(2 54-2):H579–H588.
   Google Scholar
• Buckberg GD. Studies of controlled reperfusion after ischemia. I. When is cardiac muscle damaged irreversibly? J Thorac Cardiovasc Surg. 1986;92(3 II):483–487.
   PubMed Web of Science ®Google Scholar
• Schipke JD, Halkos ME, Kerendi F, Gams E, Vinten-Johansen J. Postconditioning: A brief review. Arch Med Sci. 2006;2(3):137–145.
   Google Scholar
• Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning: A form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res. 2004;95(3):230–232.
   PubMed Web of Science ®Google Scholar
• Guo JY, Yang T, Sun XG, Zhou NY, Li FS, Long D, et al. Ischemic postconditioning attenuates liver warm ischemia–reperfusion injury through Akt-eNOS-NO-HIF pathway. J Biomed Sci. 2011;18(1).
   Web of Science ®Google Scholar
• Zhu J, Lu T, Yue S, Shen X, Gao F, Busuttil RW, et al. Rapamycin protection of livers from ischemia and reperfusion injury is dependent on both autophagy induction and mammalian target of rapamycin complex 2-akt activation. Transplantation 2015;99(1):48–55.
   PubMed Web of Science ®Google Scholar
• Grossini E, Pollesello P, Bellofatto K, Sigaudo L, Farruggio S, Origlia V, et al. Protective effects elicited by levosimendan against liver ischemia/reperfusion injury in anesthetized rats. Liver Transplant 2014;20(3):361–375.
   PubMed Web of Science ®Google Scholar
• Guo Y, Yang T, Lu J, Li S, Wan L, Long D, et al. Rb1 postconditioning attenuates liver warm ischemia–reperfusion injury through ROS-NO-HIF pathway. Life Sci. 2011;88(13-14):598–605.
   Web of Science ®Google Scholar
• Gui B, Hua F, Chen J, Xu Z, Sun H, Qian Y. Protective effects of pretreatment with oleanolic acid in rats in the acute phase of hepatic ischemia–reperfusion injury: Role of the PI3K/Akt pathway. Mediators Inflamm. 2014; 2014:1–7.
   PubMed Web of Science ®Google Scholar
• Bejaoui M, Zaouali MA, Folch-Puy E, Pantazi E, Bardag-Gorce F, Carbonell T, et al. Bortezomib enhances fatty liver preservation in Institut George Lopez-1 solution through adenosine monophosphate activated protein kinase and Akt/mTOR pathways. J Pharm Pharmacol.2014;66(1): 62–72.
   PubMed Web of Science ®Google Scholar
• Aguilar-Melero P, Luque A, Machuca MM, Pérez De Obanos MP, Navarrete R, Rodríguez-García IC, et al. Cardiotrophin-1 reduces ischemia/reperfusion injury during liver transplant. J Surg Res. 2013;181(2):E83–E91.
   Google Scholar
• Yang X, Qin L, Liu J, Tian L, Qian H. 17β-Estradiol protects the liver against cold ischemia/reperfusion injury through the Akt kinase pathway. J Surg Res. 2012;178(2):996–1002.
   PubMed Web of Science ®Google Scholar
• Zhang R, Zhang L, Manaenko A, Ye Z, Liu W, Sun X. Helium preconditioning protects mouse liver against ischemia and reperfusion injury through the PI3KPI3K/Akt pathway. J Hepatol. 2014;61:1048–1055.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Joe Y, Kong JS, Jeong S-, Cho GJ, Ryter SW, et al. Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent akt signaling and inhibition of glycogen synthase kinase 3 β;. Oxidative Med Cell Longevity 2013;2013:1–11.
   Web of Science ®Google Scholar
• Nandra KK, Collino M, Rogazzo M, Fantozzi R, Patel NSA, Thiemermann C. Pharmacological preconditioning with erythropoietin attenuates the organ injury and dysfunction induced in a rat model of hemorrhagic shock. DNM Dis Models Mech 2013;6(3):701–709.
   PubMed Web of Science ®Google Scholar
• Suo L, Kang K, Wang X, Cao Y, Zhao H, Sun X, et al. Carvacrol alleviates ischemia reperfusion injury by regulating the PI3K-Akt pathway in rats. PLoS ONE 2014;9(8): 1–10.
   Web of Science ®Google Scholar
• Koh P. Melatonin prevents hepatic injury-induced decrease in Akt downstream targets phosphorylations. J Pineal Res. 2011;51(2):214–219.
   PubMed Web of Science ®Google Scholar
• Ohi N, Nishikawa Y, Tokairin T, Yamamoto Y, Doi Y, Omori Y, et al. Maintenance of bad phosphorylation prevents apoptosis of rat hepatic sinusoidal endothelial cells in vitro and in vivo. Am J Pathol. 2006;168(4):1097–1106.
   PubMed Web of Science ®Google Scholar
• Grutzner U, Keller M, Bach M, Kiemer AK, Meissner H, Bilzer M, et al. PI 3-kinase pathway is responsible for antiapoptotic effects of atrial natriuretic peptide in rat liver transplantation. World J Gastroenterol. 2006;12(7): 1049–1055.
   PubMed Web of Science ®Google Scholar
• Sheng M, Zhou Y, Yu W, Weng Y, Xu R, Du H. Protective effect of berberine pretreatment in hepatic ischemia/reperfusion injury of rat. Transplant Proc. 2015;47(2):275–282.
   PubMed Web of Science ®Google Scholar
• Müller C, Dünschede F, Koch E, Vollmar AM, Kiemer AK. α-lipoic acid preconditioning reduces ischemia–reperfusion injury of the rat liver via the PI3-kinase/Akt pathway. Am J Physiol Gastrointest Liver Physiol. 2003;285(4 48-4):G769–G778.
   Google Scholar
• Park J, Kang J, Lee S-. Activation of the cholinergic anti-inflammatory pathway by nicotine attenuates hepatic ischemia/reperfusion injury via heme oxygenase-1 induction. Eur J Pharmacol. 2013;707(1–3):61–70.
   PubMed Web of Science ®Google Scholar
• Fu W, Liao X, Ruan J, Li X, Chen L, Wang B, et al. Recombinant human erythropoietin preconditioning attenuates liver ischemia reperfusion injury through the phosphatidylinositol-3 kinase/AKT/endothelial nitric oxide synthase pathway. J Surg Res. 2013;183(2):876–884.
   PubMed Web of Science ®Google Scholar
• Zhang T, Shu H-, Chang L, Ye F, Xu K-, Huang W-. Resolvin D1 protects against hepatic ischemia/reperfusion injury in rats. Int Immunopharmacol. 2015;28(1):322–327.
   PubMed Web of Science ®Google Scholar
• Wang D, Ma Y, Li Z, Kang K, Sun X, Pan S, et al. The role of AKT1 and autophagy in the protective effect of hydrogen sulfide against hepatic ischemia/reperfusion injury in mice. Autophagy 2012;8(6):954–962.
   PubMed Web of Science ®Google Scholar
• Hori T, Gardner LB, Hata T, Chen F, Baine A-T, Uemoto S, et al. Pretreatment of liver grafts in vivo by γ-aminobutyric acid receptor regulation reduces cold ischemia/warm reperfusion injury in rat. Ann Transplant 2013;18(1):299–313
   PubMed Web of Science ®Google Scholar
• Eldar-Finkelman H. Glycogen synthase kinase 3: An emerging therapeutic target. Trends Mol Med. 2002;8(3):126–132.
   PubMed Web of Science ®Google Scholar
• Gomez L, Paillard M, Thibault H, Derumeaux G, Ovize M. Inhibition of GSK3β by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 2008;117(21):2761–2768.
   PubMed Web of Science ®Google Scholar
• Fu H, Xu H, Chen H, Li Y, Li W, Zhu Q, et al. Inhibition of glycogen synthase kinase 3 ameliorates liver ischemia/reperfusion injury via an energy-dependent mitochondrial mechanism. J Hepatol. 2014;61(4):816–824.
   PubMed Web of Science ®Google Scholar
• Honda K, Tohyama T, Kotegawa H, Kojima Y, Kushihata F, Watanabe J, et al. Protective effect of Adeno-mediated human Bcl-xLgene transfer to the mouse liver in a partial Ischemia/Reperfusion model. J Surg Res. 2009;157(1):e107–e116.
   Google Scholar
• Kim R. Unknotting the roles of Bcl-2 and Bcl-xL in cell death. Biochem Biophys Res Commun. 2005;333(2):336–343.
   PubMed Web of Science ®Google Scholar
• Yoshidome H, Kato A, Edwards MJ, Lentsch AB. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: Implications of a central role for nuclear factor κB. Hepatology 1999;30(1):203–208.
   PubMed Web of Science ®Google Scholar
• Iwakiri Y, Kim MY. Nitric oxide in liver diseases. Trends Pharmacol Sci. 2015;36(8):524–536.
   PubMed Web of Science ®Google Scholar
• Shah V, Kamath PS. Nitric oxide in liver transplantation: Pathobiology and clinical implications. Liver Transplant 2003;9(1):1–11.
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. MTOR signaling in growth control and disease. Cell 2012;149(2):274–293.
   PubMed Web of Science ®Google Scholar
• Kang J, Cho H, Lee S. Melatonin inhibits mTOR-dependent autophagy during liver ischemia/reperfusion. Cell Physiol Biochem. 2014;33(1):23–36.
   PubMed Web of Science ®Google Scholar
• Kezic A, Becker JU, Thaiss F. The effect of mTOR-inhibition on NF-κB activity in kidney ischemia–reperfusion injury in mice. Transplant Proc. 2013;45(5):1708–1714.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Yoshidome H, Kimura F, Shimizu H, Ohtsuka M, Takeuchi D, et al. Hepatocyte apoptosis is enhanced after ischemia/reperfusion in the steatotic liver. J Clin Biochem Nutr. 2011;48(2):142–148.
   PubMed Web of Science ®Google Scholar
• Johnson CR, Jarvis WD. Caspase-9 regulation: An update. Apoptosis 2004;9(4):423–427.
   PubMed Web of Science ®Google Scholar
• Tsalkidou EG, Tsaroucha AK, Chatzaki E, Lambropoulou M, Papachristou F, Trypsianis G, et al. The effects of apigenin on the expression of Fas/FasL apoptotic pathway in warm liver ischemia–reperfusion injury in rats. Bio Med Res Int 2014; 2014:1–7.
   Google Scholar
• Van Rooij E, Purcell AL, Levin AA. Developing MicroRNA therapeutics. Circ Res. 2012;110(3):496–507.
   PubMed Web of Science ®Google Scholar
• Shen G, Li X, Jia Y, Piazza GA, Xi Y. Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin. 2013;34(3):336–341.
   PubMed Web of Science ®Google Scholar
• Morita T, Ishikawa M, Sakamoto A. Identical microRNAs regulate liver protection during anaesthetic and ischemic preconditioning in rats: An animal study. PLoS ONE 2015;10(5).
   Web of Science ®Google Scholar
• Sun G, Zhou Y, Li H, Guo Y, Shan J, Xia M, et al. Over-expression of microRNA-494 up-regulates hypoxia-inducible factor-1 alpha expression via PI3K/Akt pathway and protects against hypoxia-induced apoptosis. J Biomed Sci. 2013;20(1).
   Web of Science ®Google Scholar
• Sayed D, He M, Hong C, Gao S, Rane S, Yang Z, et al. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of fas ligand. J Biol Chem. 2010;285(26):20281–20290.
   PubMed Web of Science ®Google Scholar
• Edelstein ML, Abedi MR, Wixon J, Edelstein RM. Gene therapy clinical trials worldwide 1989–2004–An overview. J Gene Med. 2004;6(6):597–602.
   PubMed Web of Science ®Google Scholar
• Song J, Zhang Y, Yao A, Yu Y, Hua Z-, Pu L-, et al. Adenoviral cardiotrophin-1 transfer improves survival and early graft function after ischemia and reperfusion in rat small-for-size liver transplantation model. Transplant Int. 2008;21(4):372–383
   PubMed Web of Science ®Google Scholar
• Jia W, Li H, He Y. The extracellular matrix protein mindin serves as an integrin ligand and is critical for inflammatory cell recruitment. Blood 2005;106(12):3854–3859.
   PubMed Web of Science ®Google Scholar
• Sun P, Zhang P, Wang P-, Zhu L-, Du Y, Tian S, et al. Mindin deficiency protects the liver against ischemia/reperfusion injury. J Hepatol. 2015;63(5):1198–1211.
   PubMed Web of Science ®Google Scholar
• Hai T, Wolford CC, Chang Y-. ATF3, a hub of the cellular adaptive-response network, in the pathogenesis of diseases: Is modulation of inflammation a unifying component? Gene Expr. 2010;15(1):1–11.
   PubMed Web of Science ®Google Scholar
• Rao J, Qian X, Li G, Pan X, Zhang C, Zhang F, et al. ATF3-mediated NRF2/HO-1 signaling regulates TLR4 innate immune responses in mouse liver ischemia/reperfusion injury. Am J Transplant. 2015;15(1):76–87.
   PubMed Web of Science ®Google Scholar
• Bataille AM, Manautou JE. Nrf2 a potential target for new therapeutics in liver disease. Clin Pharmacol Ther. 2012;92(3):340–348.
   PubMed Web of Science ®Google Scholar
• Huang J, Yue S, Ke B, Zhu J, Shen X, Zhai Y, et al. Nuclear factor erythroid 2-related factor 2 regulates toll-like receptor 4 innate responses in mouse liver ischemia–reperfusion injury through Akt-forkhead box protein O1 signaling network. Transplantation 2014;98(7):721–728.
   PubMed Web of Science ®Google Scholar